追踪五十年的牛皮药物治疗:一个大规模的用人工智能指导的术语规范化标准化文献计量调查
Ada Radu1,2, Andrei-Flavius Radu1,3, Gabriela S Bungau1,2
1Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.
Pharmaceuticals (Basel, Switzerland)
|September 27, 2025
概括
图书统计分析显示,牛皮的药物治疗研究在过去的五十年里有了显著的进化. 这一转型突显了其向精准医学和针对免疫媒介疾病的向治疗的转变.
科学领域:
- 图书统计学 图书统计学
- 药物治疗 药物治疗
- 皮肤病学 皮肤病学
- 精准医学是一门精准的医学.
背景情况:
- 关于牛皮药物治疗研究的有限的大规模图书统计评估存在.
- 牛皮的研究在一个快速发展的领域取得了显著的成果.
- 了解研究轨迹可以阐明医疗领域的转型.
研究的目的:
- 绘制五十年来系统性牛皮治疗研究的演变图.
- 展示文献识别分析如何阐明专业医疗领域的转变.
- 展示牛皮病研究在精准医学中的整合.
主要方法:
- 从Web of Science获得的19284篇出版物 (1975-2025) 的综合图书统计分析.
- 人工智能增强的术语规范化用于制药命名标准化.
- 用于网络可视化,趋势分析和主题映射的VOSviewer和Bibliometrix套件.
主要成果:
- 出版物产量从9 (1975) 增长到1638 (2024);美国领导产量,加拿大领导引用效率.
- 全球合作涉及70个国家;引用影响在2001-2008年达到顶峰,随着生物治疗的引入.
- 主题演变显示了从基本免疫学转向向治疗 (TNF抑制剂到IL-17/IL-23和JAK抑制剂).
结论:
- 牛皮治疗研究从一个利基领域转变为免疫介导疾病创新的模式.
- 图书计量方法捕捉科学动态,为制药创新和精准医学提供见解.
- 这种演变强调了文献计量学在指导炎症疾病研究优先事项方面的战略价值.
相关概念视频
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
228
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
228
Therapeutic Drug Monitoring: Overview and Classification
309
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
309
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Inflammatory Bowel Disease IV: Pharmacological Management
521
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
521


